These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
581 related items for PubMed ID: 18420288
1. Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35). Tsunekawa H, Noda Y, Mouri A, Yoneda F, Nabeshima T. Behav Brain Res; 2008 Jul 19; 190(2):224-32. PubMed ID: 18420288 [Abstract] [Full Text] [Related]
3. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents. de Bruin NM, Prickaerts J, Lange JH, Akkerman S, Andriambeloson E, de Haan M, Wijnen J, van Drimmelen M, Hissink E, Heijink L, Kruse CG. Neurobiol Learn Mem; 2010 May 19; 93(4):522-31. PubMed ID: 20132903 [Abstract] [Full Text] [Related]
4. Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice. Cachard-Chastel M, Devers S, Sicsic S, Langlois M, Lezoualc'h F, Gardier AM, Belzung C. Behav Brain Res; 2008 Mar 05; 187(2):455-61. PubMed ID: 18061284 [Abstract] [Full Text] [Related]
5. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil. Sharma B, Singh N, Singh M. J Psychopharmacol; 2008 Mar 05; 22(2):162-71. PubMed ID: 18208924 [Abstract] [Full Text] [Related]
6. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Meunier J, Ieni J, Maurice T. Br J Pharmacol; 2006 Dec 05; 149(8):998-1012. PubMed ID: 17057756 [Abstract] [Full Text] [Related]
7. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease. Bitner RS, Bunnelle WH, Decker MW, Drescher KU, Kohlhaas KL, Markosyan S, Marsh KC, Nikkel AL, Browman K, Radek R, Anderson DJ, Buccafusco J, Gopalakrishnan M. J Pharmacol Exp Ther; 2010 Sep 01; 334(3):875-86. PubMed ID: 20504913 [Abstract] [Full Text] [Related]
8. Comparison of donepezil and memantine for protective effect against amyloid-beta(1-42) toxicity in rat septal neurons. Kimura M, Komatsu H, Ogura H, Sawada K. Neurosci Lett; 2005 Dec 31; 391(1-2):17-21. PubMed ID: 16154269 [Abstract] [Full Text] [Related]
9. Procognitive effect of AC-3933 in aged mice, and synergistic effect of combination with donepezil in scopolamine-treated mice. Hashimoto T, Hatayama Y, Nakamichi K, Yoshida N. Eur J Pharmacol; 2014 Dec 15; 745():123-8. PubMed ID: 25446931 [Abstract] [Full Text] [Related]
10. Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice. Yamada M, Hayashida M, Zhao Q, Shibahara N, Tanaka K, Miyata T, Matsumoto K. J Ethnopharmacol; 2011 Jun 01; 135(3):737-46. PubMed ID: 21513784 [Abstract] [Full Text] [Related]
11. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model. Puri V, Wang X, Vardigan JD, Kuduk SD, Uslaner JM. Behav Brain Res; 2015 Jun 01; 287():96-9. PubMed ID: 25800972 [Abstract] [Full Text] [Related]
12. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan. Nozawa M, Ichimiya Y, Nozawa E, Utumi Y, Sugiyama H, Murayama N, Iseki E, Arai H. Psychogeriatrics; 2009 Jun 01; 9(2):50-5. PubMed ID: 19604325 [Abstract] [Full Text] [Related]
13. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine. Nagakura A, Shitaka Y, Yarimizu J, Matsuoka N. Eur J Pharmacol; 2013 Mar 05; 703(1-3):53-61. PubMed ID: 23276665 [Abstract] [Full Text] [Related]
14. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Saxena G, Singh SP, Agrawal R, Nath C. Eur J Pharmacol; 2008 Mar 10; 581(3):283-9. PubMed ID: 18234183 [Abstract] [Full Text] [Related]
15. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat. Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, Matsuno T, Kawashima S, Nabeshima T. J Pharmacol Exp Ther; 2006 Jun 10; 317(3):1079-87. PubMed ID: 16474004 [Abstract] [Full Text] [Related]
16. Effects of selegiline alone or with donepezil on memory impairment in rats. Takahata K, Minami A, Kusumoto H, Shimazu S, Yoneda F. Eur J Pharmacol; 2005 Aug 22; 518(2-3):140-4. PubMed ID: 16061218 [Abstract] [Full Text] [Related]
17. Tartary buckwheat improves cognition and memory function in an in vivo amyloid-β-induced Alzheimer model. Choi JY, Cho EJ, Lee HS, Lee JM, Yoon YH, Lee S. Food Chem Toxicol; 2013 Mar 22; 53():105-11. PubMed ID: 23219778 [Abstract] [Full Text] [Related]
18. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Prediger RD, Medeiros R, Pandolfo P, Duarte FS, Passos GF, Pesquero JB, Campos MM, Calixto JB, Takahashi RN. Neuroscience; 2008 Feb 06; 151(3):631-43. PubMed ID: 18191900 [Abstract] [Full Text] [Related]
19. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice. Dall'Igna OP, Fett P, Gomes MW, Souza DO, Cunha RA, Lara DR. Exp Neurol; 2007 Jan 06; 203(1):241-5. PubMed ID: 17007839 [Abstract] [Full Text] [Related]
20. Evaluation of neuroprotective effect of quercetin with donepezil in scopolamine-induced amnesia in rats. Pattanashetti LA, Taranalli AD, Parvatrao V, Malabade RH, Kumar D. Indian J Pharmacol; 2017 Jan 06; 49(1):60-64. PubMed ID: 28458424 [Abstract] [Full Text] [Related] Page: [Next] [New Search]